Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early …

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease.

Source: google.com

Scroll to Top